Peer Review History
| Original SubmissionDecember 12, 2024 |
|---|
|
Dear Dr. Mukherjee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 24 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Chiranjivi Adhikari, MPH, MHEd., PhD Candidate Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Thank you for stating the following in your Competing Interests section: “Not applicable” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments (if provided): Dear Authors, It's an interesting piece of scientific task, with well documented and reviewed reseach questions, hypothesis, and methodologies. The write up is good except with some errors and some analyses to be carried out as follows as minor revisions; 1. As also the reviewers have noted, there are errors, such as in line 158, citation 4 with ?; in 163, 95% CI missed; in 165, citation missed; in 296/299/360 and so many texts, inconsistencies between chi2 and chi-square?! 2. Similarly, some text are missing, such as line297, only 1, and 'table' is missing.. 3. The table 2 shows 10 hypotheses, but below interpretation is only about three, also describe and mention the other hypotheses. 4. in line 197, write in sentence case. 5. Line 305, write in sentence case. Followings are as major revisions: 6. For AUCs, Precision, Recall, and F1-Scores, also report 95% CIs. 7. We may only obtain the information as to how well the model ranks positive vs. negative cases, true positive rate, and other performances but limited to individual model; from AUCs, Precision, Recall, and F1-Scores. However, to compare, as for policy and clinical decision making, there should be direct comparision, which is lacking, so, head-to-head tests like DeLong’s test (for comparing AUCs statistically) and/or Bootstrap tests (to get confidence intervals on the given parameters) are recommended with consultations of statistician (senior). 8. Similarly, AUCs and other parameters as mentioned may only consider ranking, not class label predictions, and so on. Therefore, McNemar test to observe whether the number of disagreements between two classifiers is statistically significant, as with a head-to-head comparison, or similar other to compare all, are strongly advised (with statistician). 9. Similarly, the tests you have carried out may not show how performance may vary across samples or resamples, which may miss the variance and stability of performance across datasets or folds. So, for practicality, as for public health decision making, also consult for permutation tests to evaluate whether a model performs significantly better than chance or another model under label shuffling; and/or cross-validated paired t-tests or Wilcoxon signed-rank tests across folds for robust model comparison. Additionally, for better readibility, for readers who are not very comfortable with such statistics, and tests, consider the tests like decision curve analysis and Calibration plots (how well predicted probabilities reflect true likelihood). Finally, also kindly addresss the comments from both reviewers, for which I greatly acknowledge their times. Chiranjivi, AE, Plos [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: The aim of this research is to explore the complex multimorbid phenomenon and to inform public health policy makers in designing smart prediction based decision making to avoid delay in specific intervention areas and increasing the targeting accuracy. Classical and machine learning models are applied to identify the best model in classifying the individuals falling in this typical subgroup to help the health system design customized solutions. However, the manuscript seems to have many limitations including the followings: (i) There are many such works in the domain. What are the limitations of those studies? What is the significance of your work over others' works? (ii) You should separately present the related work in a new section. Moreover, you should present a summary table for the related works. (iii) You should have an organization paragraph at the end of your introduction section. (iv) In the fifth page of your manuscript, you missed many references. Please check that. (v) You should use proper reference for the dataset, not only just the Kaggle. (vi) The quality of the images used in this manuscript are very bad. (vii) Your material and method section is very poorly presented. (viii) The performances of different machine learning are not satisfactory. Moreover, you have not compared your results with that of others. (ix) Your research contributions are not satisfactory, except some analysis. Reviewer #2: The subject of the study is quite interesting with the findings impactful. The manuscript is well written, and the methodology and research design are scientific and sound. The results are reported well, however, there are still areas of improvement in following areas: 1. Referencing should be uniform in whole papaer, "line no. 40, 46, 58, 82 96" also in others if any..You have mentioned as Rosenkilde et al. (30) in 82 and (WHO, 2020) in 96. which one is correct ? please make uniformity and follow the journal guideline 2. line no. 120 need to rewrite as " A prospective experimental study by.... tested the link between loneliness and the onset of T2D symptoms using data from the Danish National Health Survey (ref) which includes 465290 participants older than 16 years." 3. line no. 165 and 169 " . Another study by Uphoff et al. (? ) ................. explored the impact of behavioural an impact on efficacy (? ). Cannot understand reference missing or what do you want to write ? please correct. 4. line no. 185, cannot figure out the line concept. please clarify. i think the sentence structure should be in correct order. 5. line no. 297- 299 . make uniformity in the test type. Chi2 test or chi-square test. 6. regarding methodoligical choices: The study discusses various classical and machine learning methods, but it does not provide in-depth justification for the chosen methods over others and may overlook potential biases introduced by these choices. please justify. 7. table 2 seems out of page please correct it. cannot see the full table in paper layout. 8. Add one paragraph for policy implications in the future direction section which will make this papaer more compresensive 9. Conclusion: duplication must be avoided. write breifly by addressing your research objectives. 10. Add information about the strength of your study before the limitation. Overall, the discussion section reads well.Thank you and best wishes ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Sujan Poudel ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Classifying Complex Multimorbidity Using Latent Class Analysis and Machine Learning to Generate Insights into Clustering of Mental and Cardiometabolic Conditions PONE-D-24-56938R1 Dear Dr. Moumita Mukherjee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Chiranjivi Adhikari, MPH, MHEd., PhD Candidate Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-56938R1 PLOS ONE Dear Dr. Mukherjee, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Mr. Chiranjivi Adhikari Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .